Babies’ Genomes Identify Risks Overlooked by Newborn Screens
Babies’ Genomes Identify Risks Overlooked by Newborn Screens
A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.
A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.
BabySeq
Q&A: Sequencing Newborns
Tracy Vence | Oct 21, 2016 | 2 min read
Members of the BabySeq Project discuss trial enrollment, preliminary findings.